Navigation Links
China Medical Technologies Reports Third Fiscal Quarter Financial Results
Date:2/18/2011

rough its direct sales personnel and ECLIA reagent kits to small and mid-size hospitals through distributors. For more information, please visit http://www.chinameditech.com.

Safe Harbor StatementThis press release contains forward-looking statements. These statements constitute "forward-looking" statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the quotations from management in this press release, as well as its outlook for 4Q FY2010 and full year FY2010, contain forward-looking statements. Such statements involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Further information regarding these and other risks is included in the Company's filings with the U.S. Securities and Exchange Commission, including its annual report on Form 20-F. The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under applicable law.

ContactsSam Tsang and Winnie YamTel: 852-2511-9808Email: IR@chinameditech.comChina Medical Technologies, Inc.Unaudited Condensed Consolidated Balance SheetsAs ofSeptember 30, 2010December 31, 2010RMBRMB US$(in thousands)AssetsCurrent assetsCash and cash equivalents

805,901

1,119,384

169,604Trade accounts receivable, net

333,123

397,739

60,264Inventories

21,351

16,640

2,521Prepayments and other receivables

19,093

9,503


'/>"/>

SOURCE China Medical Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine technology :

1. China SHESAYS Updates on Progress of Commencing Operations at its New Flagship Hospital
2. ThermoGenesis Reports Second Quarter 2011 Results; Increased Presence in China
3. China-Biotics, Inc. Reports Record Quarterly Net Sales for the Third quarter of Fiscal Year 2011
4. China Medicine Corporation Receives Manufacturing License for rADTZ
5. China SHESAYS Announces Preliminary Unaudited Results for FY 2010; Provides Business Outlook Update for Investors
6. China Medical Technologies to Announce Results for the Third Fiscal Quarter Ended December 31, 2010 on February 18, 2011
7. China Sky One Medical Receives Medical Industry Awards
8. Boston Scientific Begins Clinical Trial Enrollment in China for PROMUS Element™ Everolimus-Eluting Stent
9. Reportlinker Adds The Top 10 CMOs in China
10. Shareholder Letter from Chairman of China Sky One Medical
11. Wolters Kluwer Health Enters Joint Venture with China Drug Information Provider Medicom
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... -- Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX ), a late-stage ... Locilex® (pexiganan cream 0.8%), a novel, broad spectrum, topical ... investor conferences in September. , ... LLC Emerging Growth Conference in New ... President & Chief Executive Officer, will present a corporate ...
(Date:8/31/2015)... , August 31, 2015 ... BOLT, OTCQX: BLGTY) ("BioLight" or the "Company"), a ... innovations in ophthalmology and cancer diagnostics, today announced ... MCTC), has identified several new genetic markers with ... in patients treated with bisphosphonate drugs and was ...
(Date:8/31/2015)... Calif. , Aug. 31, 2015  Asterias ... focused on the emerging field of regenerative medicine, ... dosed at Chicago -based Rush ... trial evaluating activity of escalating doses of AST-OPC1 ... sensory and motor complete cervical spinal cord injury ...
Breaking Medicine Technology:Dipexium Pharmaceuticals Announces Participation in Four Investor Conferences in September 2Dipexium Pharmaceuticals Announces Participation in Four Investor Conferences in September 3BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 2BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 3BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6
... Calif., Oct. 7 Onyx Pharmaceuticals, Inc. (Nasdaq: ... its New Drug Application (NDA) filing for carfilzomib based ... Controls (CMC) review division of the U.S. Food and ... information related to commercial-scale manufacturing of carfilzomib.  Onyx had ...
... NEW YORK, Oct. 7 Reportlinker.com announces that a ... European RIS/PACS Market ... European RIS/PACS market in terms of the challenges faced ... The main chapters of the research service include an ...
Cached Medicine Technology:Onyx Pharmaceuticals Provides Status Update on Carfilzomib 2Onyx Pharmaceuticals Provides Status Update on Carfilzomib 3Reportlinker Adds European RIS/PACS Market 2Reportlinker Adds European RIS/PACS Market 3
(Date:8/31/2015)... ... ... to undergoing a hair transplant, most patients have donor hair moved from one part of ... on top of the scalp, as well as filling in areas missing hair, is a ... areas of their head. , What about patients who have a limited, or even depleted, ...
(Date:8/31/2015)... ... August 31, 2015 , ... India Network Foundation, a non-profit ... tool, which summarizes all available plans, plan maximums, pre-existing condition coverage limits and ... help India Network members make an informed decision regarding the care they want ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... The Lisle ... Firm Partner William Scott has been nominated by his peers to earn a “Leading ... than five percent of attorneys in the state of Illinois. The nomination process is ...
(Date:8/31/2015)... ... August 31, 2015 , ... The 2015 New York ... and family members, medical professionals, and researchers, covering a variety of topics related ... a collaborative effort between the Mesothelioma Applied Research Foundation and Memorial ...
(Date:8/31/2015)... ... August 31, 2015 , ... CareSource, a nonprofit ... Communications. In this capacity, Michael will provide strategic leadership for CareSource’s marketing, branding, ... consumer-focused programs that have contributed to the company’s rapid growth. As the CareSource ...
Breaking Medicine News(10 mins):Health News:Body Hair Transplants to Help Achieve a Full Head of Hair 2Health News:India Network proudly launches the new InstantQuote tool to help choose right visitor health insurance with pre-existing conditions to US bound visitors 2Health News:DuPage County Family Law Attorney Named Illinois Leading Lawyer 2Health News:New York Experts on Mesothelioma Come Together at Memorial Sloan Kettering Cancer Center 2Health News:New York Experts on Mesothelioma Come Together at Memorial Sloan Kettering Cancer Center 3Health News:CareSource Names Vice President, Marketing and Corporate Communications 2
... opening in September 2009 - ,Those studying in Edinburgh will be able ... provider UNITE opens a brand new development overlooking the Meadows this September ... ... for the new property in Chalmers Street has been opened to give ...
... (MCA) recently honored twelve (12) doctors for their endless dedication to ... those among them who have consistently supported the profession through their ... , ... Dr. Douglas Edwards, Albert Lea, MN , ...
... Breakthrough caregiver training to revolutionize senior home care ... Assistance of Palo Alto, California released its new ... Method(TM). This system, exclusive to Home Care Assistance ... North America with an emphasis on lifestyle, healthy ...
... - Bioniche Life Sciences Inc. ("Bioniche"; TSX: BNC), ... an update on its Phase III clinical program ... On March 31st, the Company announced that recruitment ... registration trial evaluating Urocidin in the treatment of ...
... intrinsic goals is what leads to well-being , , FRIDAY, May ... and fame may sound like a sure ticket to happiness, ... University of Rochester in New York tracked 147 college graduates, ... time -- one year after graduation, and then 12 months ...
... 22 Researchers at Roswell Park Cancer Institute (RPCI) in ... the need to vaccinate both young men and women against ... comes amid growing evidence that certain cancers of the head ... strain of the human papillomavirus (HPV) that is one of ...
Cached Medicine News:Health News:It's Park Life for Edinburgh Students as Unite Unveils New Property Overlooking The Meadows 2Health News:It's Park Life for Edinburgh Students as Unite Unveils New Property Overlooking The Meadows 3Health News:It's Park Life for Edinburgh Students as Unite Unveils New Property Overlooking The Meadows 4Health News:Home Care Assistance's Exclusive Balanced Care Method(TM) Designed to Promote Longer, Healthier Lives 2Health News:Home Care Assistance's Exclusive Balanced Care Method(TM) Designed to Promote Longer, Healthier Lives 3Health News:Bioniche Phase III Clinical Trial with Urocidin(TM) Progressing Well 2Health News:Bioniche Phase III Clinical Trial with Urocidin(TM) Progressing Well 3Health News:Looks, Money, Fame Don't Bring Happiness 2Health News:Sexually Transmitted HPV Linked to Certain Head & Neck Cancers 2Health News:Sexually Transmitted HPV Linked to Certain Head & Neck Cancers 3
... therapeutic, expandable turning surface for the BariMaxx™ ... Prevention and treatment of pressure ulcers, Large ... patients using a statuc mattress that would ... whose body weight and size pose a ...
... 300 is a healthcare bed system which ... in the home care setting, ,INDICATIONS: ... weight of 2) ,Healthcare frame accommodating ... size selected, ,CONTRAINDICATIONS: ,Total weight in ...
... A Bariatric bed providing a flexible environment ... relief mattress system for comfort, support, treatment ... up to 850 lbs. ,Large patients at ... using a static mattress that would benefit ...
... Rest Deluxe Transport beds feature folding head end and ... storage. With the head end and foot end deck ... reduced to approximately 67". This compact length makes storage, ... ,This feature is not available on Model 4748B, ...
Medicine Products: